# A two-part nanozyme targets the inflammatory loop linked to colon cancer

Source: [Nanowerk Nanotechnology and Emerging Technologies News](https://www.nanowerk.com/nanotechnology-news3/newsid=70588.php?utm_source=rss&utm_medium=rss) · 2026-11-11 · Physics
Page: https://themorning.science/story/a-two-part-nanozyme-targets-the-inflammatory-loop-linked-to-colon-cancer-85c5d502540c7746
Kind: research · Impact: low

## In brief

- Researchers combined an antioxidant nanomaterial with a chemokine-binding cell membrane to form a two-part nanozyme.
- The nanozyme reduced tumor development in mouse models of colitis-associated cancer, according to the Nanowerk report.
- The work targets the inflammatory loop linked to colon cancer; the source reports results in mice only.

## Why it matters

It shows a proposed strategy that disrupts inflammation driving colitis-associated colon cancer, a possible direction for future therapies, though results so far come from animal models.

## Timeline

- 2026-11-11: Nanowerk reports the two-part nanozyme reducing tumor development in mouse models of colitis-associated cancer

## Coverage

- [A two-part nanozyme targets the inflammatory loop linked to colon cancer](https://www.nanowerk.com/nanotechnology-news3/newsid=70588.php?utm_source=rss&utm_medium=rss) — Nanowerk Nanotechnology and Emerging Technologies News, 2026-11-11

Tags: nanozyme, colon cancer, colitis, inflammation, nanomedicine, chemokines

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science